Journal of neurology, neurosurgery, and psychiatry
The most recent articles from:
J. Neurol. Neurosurg. Psychiatr.
-
J. Neurol. Neurosurg. Psychiatr. · Jan 2024
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.
The assessment of treatment response is a crucial step for patients with relapsing-remitting multiple sclerosis on disease-modifying therapies (DMTs). We explored whether a scoring system developed within the MAGNIMS (MRI in Multiple Sclerosis) network to evaluate treatment response to injectable drugs can be adopted also to oral DMTs. ⋯ Early relapses and substantial MRI activity in the first year of treatment are associated with worse short-term outcomes in patients treated with some of the oral DMTs.